Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Krishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences Ltd. (KIMS) has steadily carved out a significant presence in the Indian healthcare sector, rooted in the ethos of delivering accessible and high-quality care. Emerging from its base in Hyderabad, the institution has expanded its reach through a network of multispecialty hospitals spread across several states in southern and western India. KIMS has built its reputation on providing a broad spectrum of healthcare services, ranging from basic preventive care to advanced super specialty treatments. By blending cutting-edge medical technology with a team of experienced professionals, it has positioned itself as a destination for both domestic and international patients seeking reliable medical solutions.
The financial engine of KIMS runs on its comprehensive service offerings, which cater to a wide range of medical needs. Revenue streams are generated primarily through inpatient and outpatient services, surgical procedures, diagnostic services, and pharmacy sales. By maintaining a focus on operational efficiency and leveraging economies of scale, KIMS has managed to offer competitive pricing, thus broadening its accessibility. Furthermore, the institution has strategically enhanced its profitability through partnerships, expansions, and an emphasis on sustainability within its operations. This approach not only strengthens its market position but also fuels its capability to reinvest in infrastructure, research, and development, aiming for continuous growth and innovation in the healthcare landscape.
Krishna Institute of Medical Sciences Ltd. (KIMS) has steadily carved out a significant presence in the Indian healthcare sector, rooted in the ethos of delivering accessible and high-quality care. Emerging from its base in Hyderabad, the institution has expanded its reach through a network of multispecialty hospitals spread across several states in southern and western India. KIMS has built its reputation on providing a broad spectrum of healthcare services, ranging from basic preventive care to advanced super specialty treatments. By blending cutting-edge medical technology with a team of experienced professionals, it has positioned itself as a destination for both domestic and international patients seeking reliable medical solutions.
The financial engine of KIMS runs on its comprehensive service offerings, which cater to a wide range of medical needs. Revenue streams are generated primarily through inpatient and outpatient services, surgical procedures, diagnostic services, and pharmacy sales. By maintaining a focus on operational efficiency and leveraging economies of scale, KIMS has managed to offer competitive pricing, thus broadening its accessibility. Furthermore, the institution has strategically enhanced its profitability through partnerships, expansions, and an emphasis on sustainability within its operations. This approach not only strengthens its market position but also fuels its capability to reinvest in infrastructure, research, and development, aiming for continuous growth and innovation in the healthcare landscape.
Record Revenue: KIMS Hospitals reported its highest-ever quarterly revenue, crossing INR 1,000 crore for the first time in Q3 FY '26, up 29.2% year-on-year and 3.9% quarter-on-quarter.
Margin Pressure: EBITDA margin dropped to 20.4% from 25.9% last year, mainly due to losses at new hospitals, with EBITDA itself slightly down year-on-year.
Profit Decline: PAT fell sharply to INR 52 crore, down from INR 93 crore last year and INR 72 crore last quarter.
New Hospitals Ramping Up: Several new units in Bangalore and Thane are expected to break even by Q1 FY '27, with Electronic City targeted for Q3 FY '27.
ARPOB and ARPP Growth: Average revenue per operating bed and per patient grew strongly, driven by higher-value procedures and new hospitals in high-ARPOB markets.
Debt Has Peaked: Net debt stands at about INR 2,850 crore, with management expecting it to decline as expansion CapEx is mostly complete.
Expansion Focus: No major new hospital launches planned immediately; the priority is ramping up and breaking even at recently opened units.
